Kidney function may affect new drug levels

NCT ID NCT07227922

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This early-stage study looks at how the drug clofutriben is processed in people with moderate kidney impairment compared to those with normal kidneys. Sixteen adults will receive a single dose, and researchers will measure drug levels in the blood. The goal is to see if kidney function changes how the drug behaves, which helps guide future dosing.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for MODERATE RENAL IMPAIRMENT are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Orlando Clinical Research Center

    RECRUITING

    Orlando, Florida, 32809, United States